NYSE$RMD

ResMed Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

ResMed's Q4 2022 results were announced, demonstrating revenue growth and market leadership.

ResMed Inc. reported a 4% increase in revenue, reaching $914.7 million, and a 6% rise in operating profit for the fourth quarter of fiscal year 2022. The company's diluted earnings per share stood at $1.33, while non-GAAP diluted earnings per share reached $1.49.

  • Revenue increased by 4% to $914.7 million, up 8% on a constant currency basis.
  • Gross margin grew 110 bps to 57.1%; non-GAAP gross margin grew 50 bps to 57.8%.
  • Income from operations increased 6%; non-GAAP operating profit up 4%.
  • Diluted earnings per share of $1.33; non-GAAP diluted earnings per share of $1.49.

Headline financials

Total Revenue

$915M

Previous: $876M+4.4%
EPS (adj)

$1.49

Previous: $1.35+10.4%
Gross margin

57.1%

No prior period
Non-GAAP gross margin

57.8%

No prior period
Capital Expenditures

$28.6M

Previous: $27.9M+2.6%
Free Cash Flow

$50.8M

Previous: $199M-74.4%
Net Income

$195M

Previous: $195M+0.0%
Operating Income

$255M

Previous: $242M+5.7%
Gross Profit

$523M

Previous: $491M+6.5%
Cash & Equivalents

$274M

Previous: $295M-7.3%
Total Assets

$5.1B

Previous: $4.73B+7.8%
Stock-Based Comp

$16M

Previous: $16.9M-5.3%

Revenue & EPS history

ResMed · Revenue · Quarterly

$915M

Q4 2022+4.4%vs Q4 2021
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Revenue by segment

ResMed · $812M total across 2 segments · Q4 2022

  • Total Devices
    $487M
  • Total Masks and other
    $324M

Forward guidance

ResMed is confident in their ability to grow steadily throughout fiscal year 2023 and to continue delivering for all stakeholders. They are investing in R&D to drive accelerated adoption of digital health solutions in sleep apnea, COPD, and outside-hospital care, as they progress towards their goal to improve 250 million lives in 2025.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+0.1%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+1.2%

Avg return

30 days after

49%

33 / 67 earnings

Positive

+18.7%

Q3 2024

Best reaction

-19.3%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-2.9%-2.0%-10.8%
Q2 2026-1.5%+2.1%-0.5%
Q1 2026-1.5%-2.8%+1.4%
Q3 2025+10.1%+10.9%+13.2%
Q2 2025-8.3%-5.8%-9.4%
Q1 2025+7.9%+2.9%+2.7%
Q4 2024+4.9%+2.6%+14.9%
Q3 2024+18.7%+16.4%+16.0%
Q2 2024+6.5%+9.3%+5.2%
Q1 2024-4.2%+0.5%+9.5%
Q4 2023-19.3%-19.3%-28.3%
Q3 2023+7.6%+5.4%-3.8%
Q2 2023-2.8%-1.2%-8.5%
Q1 2023-6.5%-5.6%-1.7%
Q4 2022-1.5%-3.1%-3.1%
Q3 2022-6.9%-8.5%-3.0%
Q2 2022-6.5%+0.5%+6.2%
Q1 2022-1.9%-2.1%-6.3%
Q4 2021+0.5%+0.7%+8.3%
Q3 2021-10.6%-8.6%-2.0%
Q2 2021-5.8%-3.5%-9.9%
Q1 2021+6.2%+12.1%+16.0%
Q4 2020-13.4%-13.6%-14.4%
Q3 2020+1.8%+2.0%+2.9%
Q2 2020-4.1%+0.6%-4.1%
Q1 2020+13.8%+15.7%+14.6%
Q4 2019+1.1%+3.8%+5.4%
Q3 2019+7.9%+7.6%+9.3%
Q2 2019-19.3%-21.5%-13.6%
Q1 2019+6.2%+7.3%+5.7%
Q4 2018-2.1%+0.7%+4.1%
Q3 2018-2.1%-1.4%+6.9%
Q2 2018+13.2%+15.9%+5.1%
Q1 2018+7.7%+7.4%+8.6%
Q4 2017-6.0%-2.6%+0.6%
Q3 2017-5.2%-2.7%-2.3%
Q2 2017+9.5%+7.1%+13.7%
Q1 2017-5.0%-5.3%-8.7%
Q4 2016+5.8%+6.5%+6.0%
Q3 2016-7.4%
Q2 2016+7.1%
Q1 2016+0.1%
Q4 2015+3.6%
Q3 2015-10.3%
Q2 2015+8.6%
Q1 2015+9.5%
Q4 2014-4.1%
Q3 2014-0.4%
Q2 2014-5.7%
Q1 2014-13.2%
Q4 2013+0.5%
Q3 2013+0.9%
Q2 2013+7.0%
Q1 2013-4.7%
Q4 2012+12.8%
Q3 2012+7.6%
Q2 2012+9.7%
Q1 2012-12.0%
Q4 2009-5.4%
Q4 2011-5.4%
Q3 2011-0.9%
Q3 2010-0.9%
Q2 2010+2.2%
Q2 2011+2.2%
Q1 2010+3.6%
Q1 2011+3.6%
Q4 2010+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro